Pellucid Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 2.11 Cr
as on 16-11-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 18.19 Cr
as on 16-11-2024
- Revenue -41.82%
(FY 2023)
- Profit -52.86%
(FY 2023)
- Ebitda -53.78%
(FY 2023)
- Net Worth 17.97%
(FY 2023)
- Total Assets -2.26%
(FY 2023)
About Pellucid Lifesciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.11 Cr.
The company has closed loans amounting to ₹18.19 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Imdadali Momin, Abidli Takodi, Anis Malik, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24230GJ2013PTC076652
- Company No.
076652
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Aug 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Pellucid Lifesciences Private Limited offer?
Pellucid Lifesciences Private Limited offers a wide range of products and services, including Plant Growth Promoters, Bacillus Subtilis, Fertilizers and Soil Additives, Digestive System Drugs & Medicines, Pre & Probiotic Capsule.
Who are the key members and board of directors at Pellucid Lifesciences?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Imdadali Momin  | Director | 30-Aug-2013 | Current |
| Anis Malik | Director | 30-Aug-2013 | Current |
| Abidli Takodi | Director | 30-Aug-2013 | Current |
| Arifmohammed Saiyad | Director | 30-Aug-2013 | Current |
| Hasankhan Pathan | Director | 30-Aug-2013 | Current |
| Adil Malek | Director | 30-Aug-2013 | Current |
Financial Performance of Pellucid Lifesciences.
Pellucid Lifesciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.82% decrease. The company also saw a substantial fall in profitability, with a 52.86% decrease in profit. The company's net worth Soared by an impressive increase of 17.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pellucid Lifesciences?
In 2023, Pellucid Lifesciences had a promoter holding of 100.00%. The company had 1 Joint Venture. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 03 Mar 2021 | ₹4.62 Cr | Satisfied |
Others Creation Date: 21 Dec 2020 | ₹4.62 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 07 Feb 2019 | ₹4.74 Cr | Satisfied |
How Many Employees Work at Pellucid Lifesciences?
Pellucid Lifesciences has a workforce of 57 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pellucid Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pellucid Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
